FDA
NRx Pharmaceuticals to File Two New-Drug Applications in 2024
Apex Labs Seeks FDA Approval for Study on Psilocybin Microdosing and Driver Safety
Concerns Raised About MDMA-Assisted Psychotherapy Trials for PTSD
BetterLife’s Non-Hallucinogenic LSD Derivative Clears Safety Hurdle